Introduction

We are a bioinformatics research group in the Department of Biomedical Informatics at Harvard Medical School. We are part of the Ludwig Center at Harvard, Division of Genetics at Brigham and Women’s Hospital and Harvard-MIT Division of Health, Science, & Technology.

Our main aim is to understand the genetic and epigenetic mechanisms that underlie disease processes through computational and statistical analysis of genomic data. We are particularly interested in mutational processes in normal and cancer cells and their impact in gene regulation.

Collaborative science

We have the privilege of collaborating with a number of superb experimental laboratories at Harvard Medical School and its affiliated hospitals, as well as around the world. Our recent and current collaborators include Connie Cepko, George Daley, Steve Elledge, Konrad Hochedlinger, Mark Johnson, Mitzi Kuroda, Jordan Kreidberg, Bob Kingston, William Pu, Charlie Roberts, Chris Walsh, and Fred Winston.

Here are some consortium projects in which we are involved:

  • SMaHT (Somatic Mosaicism across Human Tissues), starting in 2023 - Do mutations accumulate in non-cancer cells? Where and how? Can those mutations lead to cancer or other diseases?
  • 4D Nucleome - What are the principles underlying three-dimensional organization of the human genome? What is the role of the nuclear architecture in gene regulation? As the Data Coordination and Analysis Center for this major NIH initiative, we will collect, process, and display all data generated in the consortium and to perform integrative analysis. Main collaborators: Peter Kharchenko (HMS), Leonid Mirny (MIT), Nils Gehlenborg (HMS), Hanspeter Pfister (Harvard) and Ting Wang (WashU).
  • Brain Somatic Mosaicism Network - The aim of this network is to characterize the spectrum of somatic variation in human brain samples and its role in psychiatric disorders. We are studying somatic mosaicism in autism with Chris Walsh (Boston Children’s) and schizophrenia with Andy Chess (Mt. Sinai).
  • Ludwig Center - This center brings together investigators from across Harvard to develop strategies to overcome the problem of therapy resistence in cancer.
  • International Cancer Genome Consortium - This is an effort by the international cancer genomics community to jointly analyze ~2,500 cancer genomes.

Latest News

Jul 2026:   Park Lab takes on a 5k

The runners of Park Lab took on a 5k together (on quite a hot day)! New lab outing tradition?

Jun 2026:   Farewell Dominika, Dominik, Joseph, and Michail!

With sadness but excitement for their futures, we said farewell to Dominik as he begins his own lab and a faculty position at Beth Israel Deaconess, and to Dominika, Joseph, and Michail who are starting their PhDs at Boston University, Tri-I, and Harvard (BIG) respectively. They will all be greatly missed in Park Lab!

Apr 2026:   Farewell Jan!

We said farewell to Jan as he wraps up his work in Park Lab and will soon be graduating from university. Park Lab is excited to send Jan off to Cambridge next year to get his Master’s Degree.

Apr 2026:   Welcome Cait!

Cait Harrigan joined Park Lab in April as our newest postdoc. She received her PhD in Computer Science from the University of Toronto with thesis work on modelling DNA repair deficiencies in cancer with mutational signatures and scaling probabilistic methods to large cohorts. Welcome Cait!

Apr 2026:   Farewell Michele!

Park Lab said goodbye to Michele on his last day with the team. He was a Bioinformatics Scientist in the lab for more than seven years! We all wish him the best of luck back at home in Italy.